Cargando…

Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome

Prenatal opioid exposure (POE) is commonly associated with neonatal opioid withdrawal syndrome (NOWS), which is characterized by a broad variability in symptoms and severity. Currently there are no diagnostic tools to reliably predict which infants will develop severe NOWS, while risk stratification...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahnke, Amanda H., Roberts, Melissa H., Leeman, Lawrence, Ma, Xingya, Bakhireva, Ludmila N., Miranda, Rajesh C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993911/ https://www.ncbi.nlm.nih.gov/pubmed/35396369 http://dx.doi.org/10.1038/s41598-022-09793-7

Ejemplares similares

Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome
por: Radhakrishna, Uppala, et al.
Publicado: (2023)

Prevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy
por: Page, Kimberly, et al.
Publicado: (2022)

Is this ‘complicated’ opioid withdrawal?
por: Parkar, S.R., et al.
Publicado: (2006)

Alleviating Symptoms of Withdrawal from an Opioid
por: Wakim, Judith H.
Publicado: (2012)

Prenatal Opioid Analgesics and the Risk of Adverse Birth Outcomes
por: Brogly, Susan B., et al.
Publicado: (2021)

Hypersynchrony in MEG spectral amplitude in prospectively-identified 6-month-old infants prenatally exposed to alcohol
por: Stephen, Julia M., et al.
Publicado: (2017)

Operational definition of precipitated opioid withdrawal
por: Dunn, Kelly E., et al.
Publicado: (2023)

Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence
por: Kaplan, Gary B., et al.
Publicado: (2023)

Prenatal Exposures Are Associated With Worse Neurodevelopmental Outcomes in Infants With Neonatal Opioid Withdrawal Syndrome
por: Benninger, Kristen L., et al.
Publicado: (2020)

Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
por: Sutter, Mary Beth, et al.
Publicado: (2022)

Identification and Treatment of Opioid Withdrawal and Opioid Use Disorder in the Emergency Department
por: Jennings, Lindsey, et al.
Publicado: (2020)

Nonpharmacological Modality of Treating Opioid Withdrawal
por: Nair, Abhijit S
Publicado: (2019)

The Role of Lofexidine in Management of Opioid Withdrawal
por: Pergolizzi, Joseph V., et al.
Publicado: (2018)

Concurrent opioid and alcohol withdrawal management
por: Colvard, Michelle
Publicado: (2023)

Opioid withdrawal behavior in spiny mice: A novel preclinical model of neonatal opioid withdrawal syndrome (NOWS)
por: Stevens, Sarah, et al.
Publicado: (2021)

Fentanyl withdrawal: Iatrogenic opioid withdrawal syndrome: case report
Publicado: (2022)

Growing Potential and Remaining Uncertainties in Assessing Prenatal Alcohol Exposure in Dry Blood Spots
por: Bakhireva, Ludmila N.
Publicado: (2020)

Atypical presentation of opioid withdrawal, an effect of adulteration
por: Mondal, Supriya Kumar, et al.
Publicado: (2012)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Dexmedetomidine Infusion to Facilitate Opioid Detoxification and Withdrawal in a Patient with Chronic Opioid Abuse
por: Upadhyay, Surjya Prasad, et al.
Publicado: (2011)

Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns
por: Esposito, Daina B., et al.
Publicado: (2022)

Risk of Postpartum Opioid Use Disorder or Opioid Overdose After Prenatal Opioid Analgesic Use
por: Camden, Andi, et al.
Publicado: (2021)

Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment
por: Kosten, Thomas R., et al.
Publicado: (2019)

A Comparison of Morphine Delivery in Neonatal Opioid Withdrawal
por: Chisamore, Brian, et al.
Publicado: (2016)

A Novel Strategy for Attenuating Opioid Withdrawal in Neonates
por: Santoro, Giovanni C, et al.
Publicado: (2016)

Acute Dystonia Following Opioid Withdrawal: An Uncommon Presentation
por: Nath, Santanu, et al.
Publicado: (2019)

Unusual presentation of opioid withdrawal as seizure in Indian population
por: Harit, Ishita, et al.
Publicado: (2022)

Unusual presentation of opioid withdrawal as seizure in Indian population
por: Harit(junior resident), Ishita, et al.
Publicado: (2022)

Managing Opioid Withdrawal in an Outpatient Setting With Lofexidine or Clonidine
por: Gripshover, Jeanne, et al.
Publicado: (2022)

Creating a standard inpatient opioid withdrawal protocol
por: Abid, Ariana, et al.
Publicado: (2022)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
por: Chavan, Niraj R., et al.
Publicado: (2017)

Trends in smoking during pregnancy stratified by the use of opioid agonist therapy and the contribution of smoking to poor outcome in neonates prenatally exposed to opioid agonist treatment
por: Kelty, Erin, et al.
Publicado: (2023)

Use of Opioid-Sparing Protocols and Perceived Postpartum Pain in Patients with Opioid Use Disorder and Chronic Prenatal Opioid Exposure
por: Townsel, Courtney, et al.
Publicado: (2023)

Blockade of 5-Hydroxytryptamine 2A Receptor Attenuates Precipitation of Naloxone-Induced Withdrawal Symptoms in Opioid-Exposed Mice
por: Li, Bing, et al.
Publicado: (2022)

Single high-dose buprenorphine for opioid craving during withdrawal
por: Ahmadi, Jamshid, et al.
Publicado: (2018)

Lofexidine for Treating Opioid Withdrawal Syndrome in Palliative Care Patients
por: Nair, Abhijit S
Publicado: (2018)

Lofexidine for acute opioid withdrawal: A clinical case series
por: Renfro, Mandy L., et al.
Publicado: (2020)

Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
por: Eudy‐Byrne, Rena, et al.
Publicado: (2021)

Addressing drivers of healthcare utilization for neonatal opioid withdrawal syndrome
por: Glait, Megan, et al.
Publicado: (2022)

Treatment of Opioid Withdrawal Syndrome Triggered by Oxycodone/Naloxone with Dexmedetomidine
por: Go, Se-Il, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lc68v48hug5guvjrmjtqumgaoo